Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Head and Neck Neoplasms 1Agnosia 1

Interventions

Ropivacaine 6Anesthesia, General 6Analgesics, Opioid 6Morphine 5Acetaminophen 5Saline Solution 4Lidocaine 4Ketamine 4Fentanyl 4Sodium Chloride 3Dexmedetomidine 3Bupivacaine 3Anesthetics, Local 3Anesthesia, Local 3Acupuncture Therapy 3trimebutine 3-thiocarbamoylbenzenesulfonate 2parecoxib 2Transcutaneous Electric Nerve Stimulation 2Tramadol 2Therapeutics 2Tea 2Surveys and Questionnaires 2Propofol 2Oxycodone 2Magnesium Sulfate 2Levobupivacaine 2Control Groups 2ramosetron 1acetaminophen, codeine drug combination 1Varenicline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Agnosia × Ketoprofen × Clear all
NCT02439034 2026-03-16

KETOCOL

Centre Oscar Lambret

Phase 2 Completed
68 enrolled
GynecologicHead & Neck

Agnosia, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡